ArticleScientific reports2026
Comparative efficacy of zinc oxide nanoparticles, MSC-derived microvesicles, and platelet-rich fibrin in rabbit tendon regeneration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tendon injuries represent a significant clinical challenge because of their poor vascularity and limited intrinsic healing potential. This study aimed to comparatively evaluate the regenerative efficacy of zinc oxide nanoparticles (ZnONPs), mesenchymal stem cell-derived microvesicles (MVs), and advanced platelet-rich fibrin (A-PRF) in promoting Achilles tendon repair in a rabbit model. Thirty-six adult New Zealand rabbits were assigned to four groups: untreated control, (0.5 mL of 0.2% sterile dispersion), (1 mL gel injected twice within one week), and A-PRF (membrane applied at surgery) groups. Standardized full-thickness Achilles tendon defects were surgically induced. The animals were euthanized at 2, 4, and 6 weeks via sedation with xylazine (5 mg/kg) followed by thiopental sodium (100 mg/kg IV). Histopathological healing scores and the mRNA expression of proinflammatory (TNF-α, IL-1β, and IL-6) and anti-inflammatory (TGF-β and IL-10) genes were analyzed via real-time PCR. Treatment resulted in the most advanced histological remodeling by week 6, characterized by continuous, well-aligned collagen fibers, minimal inflammation, and normalized cellularity. Compared with the control groups, both the ZnONPs and MVs groups presented significant downregulation of TNF-α, IL-1β, and IL-6 and concurrent upregulation of TGF-β and IL-10 (p < 0.05). Compared with ZnONPs, A-PRF induced early vascularization and fibroblast proliferation but delayed collagen maturation. ZnONPs exhibited the greatest capacity to accelerate tendon regeneration through the modulation of inflammatory mediators and collagen synthesis, suggesting their potential as cost-effective biomaterials for tendon repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.